2m 2m 2m 2m 2m 2m 2m
Quince Therap (QNCX)
NASDAQ
$16.91-$0.34 (-1.97%)
Price as of Jul 14, 2026 8:43 AM EDT- $16.9MMarket Cap
- -95.15%1-Year Change
- BiotechnologyIndustry
Quince Therap (QNCX)
$16.91-$0.34 (-1.97%)
QNCX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.25 | ||
Change | -$0.29 (-1.65%) | ||
Open | $17.61 | ||
High | $18.21 | ||
Low | $17.21 | ||
Previous Close | $17.54 | ||
Volume | 54,020 | ||
30-Day Average Volume | 29,274 | ||
1-Week Change | 1.59% | ||
1-Month Change | -7.63% | ||
1-Year Change | -95.15% | ||
3-Year Change | -94.77% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 977,963 | ||
Total Assets | $26.6M | ||
Market Cap | $16.9M | ||
Enterprise Value | -$1.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | $35.9M | ||
Free Cash Flow | -$7.6M | ||
EBIT | $30.6M | ||
EBITDA | $30.6M | ||
Net Working Capital | $16.8M | ||
EPS | $576.00 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | 0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 06/30/2026 | ||
Earnings & Revenue